BSN Broadstone Acquisition Corp

(1) The securities are held directly by Broadstone Sponsor LLP (the “Sponsor”) and indirectly by Xercise2 Ltd., Overwey Capital Ltd. and Marc Jonas, among others, each of which is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. As a result, each of the aforementioned persons may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) The Sponsor owns 7,632,575 Class B Ordinary Shares, par value $0.0001 per share (“Class B Ordinary Shares”), of Broadstone Acquisition Corp. (the “Issuer”), which are convertible into Class A Ordinary Shares, par value $0.0001 per share (“Class A Ordinary Shares”), of the Issuer, as described under the heading “Description of Securities—Ordinary Shares—Founder Shares” in the Issuer’s registration statement on Form S-1 (File No. 333-245663) (the “Registration Statement”).

(3) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(4) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

(1) The securities are held directly by the Sponsor and indirectly by Xercise2 Ltd., which is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. As a result, Xercise2 Ltd. may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(3) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

(1) The securities are held directly by the Sponsor and indirectly by Xercise2 Ltd., which is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. Hugh Osmond is the director of Xercise2 Ltd. and has voting power with respect to the securities held by Xercise2 Ltd. As a result, Hugh Osmond may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(3) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

(1) The securities are held directly by the Sponsor and indirectly by Overwey Capital Ltd., which is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. As a result, Overwey Capital Ltd. may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(3) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

(1) The securities are held directly by the Sponsor and indirectly by Overwey Capital Ltd., which is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. Edward Hawkes is the director of Overwey Capital Ltd. and has voting power with respect to the securities held by Overwey Capital Ltd. As a result, Edward Hawkes may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(3) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

(1) The securities are held directly by the Sponsor and indirectly by Marc Jonas, who is a member of the Sponsor and has voting and dispositive power over certain of the securities held directly by the Sponsor. As a result, Marc Jonas may be deemed to have beneficial ownership of such securities held directly by the Sponsor.

(2) Excludes 8,106,060 Class A Ordinary Shares issuable upon the exercise of 8,106,060 private placement warrants of the Issuer. Each private placement warrant is exercisable to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, as described under the heading “Description of Securities—Warrants—Private Placement Warrants” in the Registration Statement.

(3) Based on 30,530,301 Class A Ordinary Shares and 7,632,575 Class B Ordinary Shares outstanding as of November 16, 2020, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed with the U.S. Securities and Exchange Commission on November 16, 2020.

Item 1(a). Name of Issuer:

Broadstone Acquisition Corp.

Item 1(b). Address of Issuer’s Principal Executive Offices:

7 Portman Mews South
Marylebone, London
United Kingdom W1H 6AY

Item 2(a). Name of Person Filing:

This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

Item 2(b). Address of Principal Business Office or, if none, Residence:

The principal business address of each of the Reporting Persons is as follows:

7 Portman Mews South
Marylebone, London
United Kingdom W1H 6AY

Item 2(c). Citizenship:

See responses to Item 4 on each cover page.

Item 2(d). Titles of Classes of Securities:

Class A Ordinary Shares, par value $0.0001 per share.

Item 2(e). CUSIP Number:

G1739V 100

Item 4. Ownership

See responses to Item 9 on each cover page.

See responses to Item 11 on each cover page.

See responses to Item 5 on each cover page.

See responses to Item 6 on each cover page.

See responses to Item 7 on each cover page.

See responses to Item 8 on each cover page.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. 

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

Not Applicable.

Item 9. Notice of Dissolution of Group.

Not Applicable.

Item 10. Certification.  

Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 16, 2021